Gries Financial LLC Merck & Co., Inc. Transaction History

Gries Financial LLC

$535 Million
Q1 2024

A detailed history of Gries Financial LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gries Financial LLC holds 10,476 shares of MRK stock, worth $1.32 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

10,476

Previous 9,794 6.96%

Holding current value

$1.32 Million

Previous $1.07 Million 29.52%

% of portfolio

0.26%

Previous 0.26%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $77,229 - $89,989	682 Added 6.96%	10,476 $1.38 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $22,740 - $24,747	-227 Reduced 2.27%	9,794 $1.07 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $44,783 - $49,733	-435 Reduced 4.16%	10,021 $1.03 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $789,920 - $860,977	-7,273 Reduced 41.02%	10,456 $1.21 Million
Q1 2023 Jun 21, 2023	SELL	$102.94 - $114.86 $2.7 Million - $3.01 Million	-26,224 Reduced 59.66%	17,729 $1.89 Million

Q4 2022 Jan 10, 2023	BUY	$87.44 - $112.11 $889,964 - $1.14 Million	10,178 Added 30.13%	43,953 $4.88 Million
Q3 2022 Oct 31, 2022	BUY	$84.53 - $94.96 $60,523 - $67,991	716 Added 2.17%	33,775 $2.91 Million
Q2 2022 Aug 16, 2022	BUY	$83.49 - $94.64 $39,073 - $44,291	468 Added 1.44%	33,059 $3.01 Million
Q1 2022 Apr 29, 2022	BUY	$73.51 - $82.4 $1.56 Million - $1.75 Million	21,229 Added 186.84%	32,591 $2.67 Million
Q4 2021 Feb 02, 2022	BUY	$72.28 - $90.54 $20,093 - $25,170	278 Added 2.51%	11,362 $871,000
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $13,332 - $14,662	-186 Reduced 1.65%	11,084 $833,000
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $776,052 - $914,109	11,270 New	11,270 $887,000

Others Institutions Holding MRK

# of Institutions

3,769

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $320B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gries Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gries Financial LLC with notifications on news.

Account

Gries Financial LLC Merck & Co., Inc. Transaction History